You are here

  • Home
  • Archive
  • Volume 30, Issue 12
  • Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer – a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34)

Citation Tools

Article menu
Download PDFPDF
Clinical trial
Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer – a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34)

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Harter P, Pautier P, Van Nieuwenhuysen E, et al
Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer – a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34)
International Journal of Gynecologic Cancer 2020;30:1997-2001.